TVM LIFE SCIENCE MANAGEMENT, INC.
TVM LIFE SCIENCE MANAGEMENT, INC. is a Pre-seed, Seed, Series A, Series B, Series C+ and commercial-stage fund in the US and Europe investing in Healthcare, oncology, immunology, diabetes, metabolic-diseases, cns, neurodegeneration, pain, cardiovascular-diseases, rare-diseases, therapeutics, medical-technology and diagnostics.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+, commercial-stage
- Sectors
- Healthcare, oncology, immunology, diabetes, metabolic-diseases, cns, neurodegeneration, pain, cardiovascular-diseases, rare-diseases, therapeutics, medical-technology, diagnostics
- Invests in
- US-wide, Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 1983
- Assets under management
- $900M
- Website
- tvm-capital.com
Check size not disclosed
Thesis
TVM Life Science Management is an international venture capital firm established in 1983, exclusively focused on life science innovations since 2012. They manage approximately $900 million in AUM, with their TVM Life Science Innovation II fund closing at $478 million in October 2020. Their investment strategy is dual-pronged: financing early-stage therapeutics via a single-asset or Project-Focused Company (PFC) approach, often in partnership with Eli Lilly, and investing in differentiated commercial-stage medical technologies, diagnostics, digital health, and late-stage therapeutics. They target unmet medical needs in oncology, immunology, diabetes, CNS, pain, cardiovascular, and rare diseases, investing from pre-seed to Series C in North America and Europe.
Common questions
Does TVM LIFE SCIENCE MANAGEMENT, INC. invest at the Pre-seed stage?
Yes. TVM LIFE SCIENCE MANAGEMENT, INC. lists Pre-seed, Seed, Series A, Series B, Series C+ and commercial-stage among the stages it invests in.
Where does TVM LIFE SCIENCE MANAGEMENT, INC. invest?
TVM LIFE SCIENCE MANAGEMENT, INC. invests in the US and Europe.